miR-34b/c Regulates Wnt1 and Enhances Mesencephalic Dopaminergic Neuron Differentiation by De Gregorio, Roberto et al.
Please cite this article in press as: De Gregorio et al., miR-34b/c Regulates Wnt1 and Enhances Mesencephalic Dopaminergic Neuron Dif-
ferentiation, Stem Cell Reports (2018), https://doi.org/10.1016/j.stemcr.2018.02.006Stem Cell Reports
ArticlemiR-34b/c Regulates Wnt1 and Enhances Mesencephalic Dopaminergic
Neuron Differentiation
Roberto De Gregorio,1,11,12 Salvatore Pulcrano,1,3,12 Claudia De Sanctis,1,2 Floriana Volpicelli,1,3
Ezia Guatteo,8,9 Lars von Oerthel,4 Emanuele Claudio Latagliata,8 Roberta Esposito,1 Rosa Maria Piscitelli,8,9
Carla Perrone-Capano,1,3 Valerio Costa,1 Dario Greco,5 Stefano Puglisi-Allegra,8 Marten P. Smidt,4
Umberto di Porzio,1 Massimiliano Caiazzo,6 Nicola Biagio Mercuri,8,10 Meng Li,7 and Gian Carlo Bellenchi1,*
1Institute of Genetics and Biophysics, ‘‘Adriano Buzzati Traverso’’, CNR, 80131 Naples, Italy
2Neuromed IRCCS, 86077 Pozzilli (IS), Italy
3Deparment of Pharmacy, University of Naples Federico II, 80131 Naples, Italy
4Swammerdam Institute for Life Sciences, University of Amsterdam, 1090 GE Amsterdam, the Netherlands
5Institute of Biotechnology, University of Helsinki, 00014 Helsinki, Finland
6Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, 3584 CG Utrecht, the Netherlands
7Neuroscience and Mental Health Research Institute, School of Medicine and School of Bioscience, Cardiff University, Cardiff CF24 4HQ, UK
8Fondazione Santa Lucia IRCCS, 00143 Rome, Italy
9Parthenope University, Department of Motor Science and Wellness, 80133 Naples, Italy
10University of Tor Vergata, Department of Systems Medicine, 00133 Rome, Italy
11Present address: Department of Molecular Pharmacology, Albert Einstein College of Medicine, New York, NY 10461, USA
12Co-first author
*Correspondence: giancarlo.bellenchi@igb.cnr.it
https://doi.org/10.1016/j.stemcr.2018.02.006SUMMARYThe differentiation of dopaminergic neurons requires concerted action of morphogens and transcription factors acting in a precise and
well-defined time window. Very little is known about the potential role of microRNA in these events. By performing a microRNA-mRNA
paired microarray screening, we identified miR-34b/c among the most upregulated microRNAs during dopaminergic differentiation.
Interestingly, miR-34b/c modulates Wnt1 expression, promotes cell cycle exit, and induces dopaminergic differentiation. When com-
bined with transcription factors ASCL1 and NURR1, miR-34b/c doubled the yield of transdifferentiated fibroblasts into dopaminergic
neurons. Induced dopaminergic (iDA) cells synthesize dopamine and show spontaneous electrical activity, reversibly blocked by tetro-
dotoxin, consistent with the electrophysiological properties featured by brain dopaminergic neurons. Our findings point to a role for
miR-34b/c in neuronal commitment and highlight the potential of exploiting its synergy with key transcription factors in enhancing
in vitro generation of dopaminergic neurons.INTRODUCTION
MicroRNAs (miRNAs) are a class of small non-coding sin-
gle-strand RNA (22 nucleotides) acting as post-transcrip-
tional regulators of gene expression (Bartel and Chen,
2004). They are crucial players in several aspects of brain
development such as neurogenesis, neuronal maturation,
synapse formation, axon guidance, and neuronal plasticity
(Kapsimali et al., 2007; McNeill and Van Vactor, 2012).
Disruption of miRNA biogenesis by genetic deletion of
Dicer has been a widely used strategy to investigate the
role of miRNAs in neurodevelopmental processes (Cuellar
et al., 2008; Davis et al., 2008; Kawase-Koga et al., 2009).
Cell-type-specific deletion ofmiRNAs involved inmesence-
phalic dopaminergic (mDA) neurons causes progressive
loss of these cells (Kim et al., 2007), suggesting a pivotal
role for miRNA in mDA neuron formation, survival, and
function. A number of laboratories attempted the identifi-
cation of miRNAs involved in mDA neuron differentiation
and diseases affecting the mDA system such as Parkinson’s
disease (Kim et al., 2007; Miñones-Moyano et al., 2011;
Saba et al., 2012; Tobon et al., 2012; Yang et al., 2012).S
This is an open access article under the CInterestingly, recent works highlighted the importance
of miRNAs, miR-135a2 in particular, in determining
midbrain size and the allocation of prospective mDA pre-
cursors by modulating the extent of the Wnt signaling.
The latter takes place through direct regulation of Lmx1b,
in a context where excessive Wnt signaling has been
shown to lead to improper mDA specification (Joksimovic
and Awatramani, 2014; Nouri et al., 2015). Thus, manipu-
lation ofWnt signaling has become an attractive strategy to
define new in vitro differentiation protocols to increase the
fraction of mDA neurons.
In addition, miRNAs are also emerging as possible com-
ponents in both direct and indirect cell reprogramming
strategies. Specific miRNAs are able to potentiate tran-
scription factor-mediated conversion of mouse embry-
onic fibroblasts (MEFs) into induced pluripotent stem
cells (Judson et al., 2009; Subramanyam et al., 2011).
While two miRNAs, miR-9/9* and miR-124, are able to
convert fibroblasts into neurons (Yoo et al., 2011) or
into a specific subset of neurons if combined with
defined transcription factors (Victor et al., 2014), to
date, the ability of miRNAs to enhance dopaminergictem Cell Reports j Vol. 10 j 1–14 j April 10, 2018 j ª 2018 The Authors. 1
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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MiR-34b-5p and miR-34c-5p (hereafter named miR-
34b/c) belong to a large family of miRNAs that include
miR-34a-5p and the miR-449 cluster (449a-5p, 449b-5p,
and 449c-5p). They all share the same seed sequence and
are considered as having overlapping roles. More recently
it has been shown that miR-34a/b/c share only 20% of tar-
gets, suggesting that individual miR-34 family members
exert largely unique roles (Navarro and Lieberman, 2015).
Interestingly, miR-34b/c expression was altered in Par-
kinson’s disease (PD), where it was found significantly
downregulated in brain areas of PD patients with different
degrees of pathology, prior to the appearance of motor
dysfunction (Miñones-Moyano et al., 2011).
In this work, we identified the miR-34b/c cluster as an
additional modulator of the Wnt signaling pathway. En-
forced expression of miR-34b/c significantly increases
in vitro differentiation of DA neurons. We show that miR-
34b/c is able to directly bind the Wnt1 30UTR and to
regulate its expression. Consistently, overexpression of
miR-34b/c leads to reduction ofWnt1 and Lmx1b inDA-dif-
ferentiated mouse embryonic stem cells (mESCs). In com-
bination with the induced dopaminergic (iDA)-specific
transcription factors ASCL1 and NURR1 (Caiazzo et al.,
2011), miR-34b/c doubles the transdifferentiation effi-
ciency, leading to the generation of functional iDAneurons
with characteristic electrophysiological properties.RESULTS
Modulation of the Wnt Pathway during mDA Neuron
Differentiation
To investigate the roles of miRNAs in DA neuron fate spec-
ification, we performed a microarray screen and measured
the expression of both mRNAs and miRNAs during DA dif-
ferentiation of epiblast-derived stem cells (epiSCs) using a
monolayer differentiation (MD) method developed previ-
ously (Jaeger et al., 2011). As a control, the same cells
were differentiated in the basal condition without Sonic
Hedgehog (SHH) and fibroblast growth factor 8 (FGF8),
leading to the production of mostly GABAergic neurons.
Samples were harvested at day 9 and day 14MD (Figure 1A)
and the RNAs processed for gene expression formRNAs and
miRNAs by microarray. To evaluate the activation of spe-
cific differentiation programs, we analyzed the expression
of genes involved in developmental fate specifications
and neuronal maturation at day 9 and day 14 MD in DA
and control samples. In SHH/FGF8-treated cells mDA-asso-
ciated transcripts were upregulated at both day 9 and day
14while the expression ofmarkers for GABAergic, glutama-
tergic, or adrenergic neurons were downregulated. Further-2 Stem Cell Reports j Vol. 10 j 1–14 j April 10, 2018more, we did not find any difference between the two
conditions in the expression of markers for anterior/poste-
rior identity (Figure 1B). The induction of DA fate was
further confirmed by following the expression of selected
mDA markers such as Th, Nurr1, Pitx3, Dmrt5, Foxa2a,
and Lmx1a. All these genemarkers showed a robust upregu-
lation at the end the differentiation protocol in cultures
treatedwith SHH and FGF8 (Figure 1C). In contrast, general
neuronal markers, such as Tubb3, Ascl1, Map2, and Ngn2,
have a similar expression profile in both DA and control
conditions (Figure 1D). Consistent with the transcript anal-
ysis, immunostaining for tyrosine hydroxylase (TH) and
GFP (for PITX3-GFP) at the end of the differentiation proto-
col confirmed the generation of DA neurons (Figure 1E).
By comparing gene expression profiles at day 9 and day
14 MD in SHH/FGF8-treated samples (david.ncifcrf.gov)
(Huang et al., 2007a), we noticed that the Wnt signaling
pathway becomes one of the most affected KEGG (Kyoto
Encyclopedia of Genes and Genomes) pathways along
the DA differentiation (Figure 2A).
We have previously performed microarray screening
comparing the floor plate (ventral midbrain, mDA) versus
basal plate (non-DA) transcripts at three embryonic time
points: embryonic day 9.5 (E9.5), E10.5, and E12.5 (Gennet
et al., 2011). Reanalysis of this dataset revealed that only five
Wnts (Wnt1, Wnt5a, Wnt5b, Wnt7a, and Wnt9a) are ex-
pressed at E9.5 but their expression decreases progressively
until E12.5 (Figure 2B). The same genes were also affected
in our microarray dataset, from day 9 and day 14 MD. By
comparing epiSC differentiated toward an mDA phenotype
with cells differentiated in control condition, giving rise to
mainly GABAergic neurons, we found by qPCR that
Wnt5a,Wnt5b, andWnt9a increasedduringmDAdifferenti-
ationwhileWnt1wasmaintainedata lower level (Figure2C).
The reduction ofWnt1was paralleled by that of Lmx1b (Fig-
ure 2C), a transcription factor known to be involved in early
stages ofMHB formation (Guo et al., 2007) andwas recently
associated with Wnt1 as part of a regulatory loop together
with miR-135a2-5p (Anderegg et al., 2013). Interestingly,
the analysis of the array data show that most of the genes
that positively affect theWnt signalingwere downregulated
at day 14 MD, while some known inhibitors of the Wnt
pathway, such as Gsk3b or Ctnnbip1, were upregulated (Fig-
ure2Dandscheme inFigure2E).Together, thesedata suggest
that the regulation of Wnt signaling during DA differentia-
tion isneeded toachievepropergenerationofmDAneurons.
Mir-34b/c Targets Wnt1 and Is Enriched in Purified
PITX3-GFP+ mDA Neurons
To test the hypothesis that negative regulation of the Wnt
pathway could be achieved through the action of miRNAs,
we screened miRNA-specific array data for miRNAs upre-

































































































































































































































Figure 1. Profiling of epiSC-Derived Dopaminergic Cells
(A) Schematic representation of the protocols used to profile miRNAs and mRNAs expression during DA differentiation of mouse epiSCs.
RNA samples were harvested in triplicate on day 9 MD and day 14 MD.
(B) The expression of genes representative for specific developmental fate and for different neuronal populations is shown at day 9 and day
14 MD. Data are presented as log(DA/Ctrl).
(C and D) qPCR for the expression of (C) DA-specific markers or (D) general neuronal markers over the differentiation protocol from day 6 MD
to day 14 MD. All qPCR data have been normalized to the average of the reference gene Hmbs. The highest value for each gene (among
both +SHH/FGF8 and SHH/FGF8 samples) was set to 1. All other values are expressed as a ratio of 1. Data represent mean ± SEM from
three independent experiments.
(E) Pitx3-GFP epiSC at day 14 MD differentiated in the presence (+) or absence () of SHH and FGF8 and immunostained for TH (red) and
GFP (green) expression. High-magnification images for TH (yellow) with DAPI (blue) counterstain. Scale bars represent 200 mm and
100 mm, respectively, for the low- and high-magnification images.
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(Agarwal et al., 2015) we scanned for all miRNAs upregu-
lated both at day 9 and at day 14, in SHH/FGF8-treated cellscompared with controls, which are predicted to bind to the
30 UTR of downregulated genes in the Wnt signaling























Term Count % P-Value Benjamini
Pathways in cancer 197 2,1 7,0E-14 1,4E-11
Axon guidance 89 0,9 5,3E-10 5,2E-8
MAPK signaling pathway 157 1,7 7,6E-10 4,9E-8
Cell cycle 83 0,9 5,8E-8 2,8E-6
Renal cell carcinoma 50 0,5 5,7E-7 2,2E-5
Wnt signaling pathway 89 0,9 3,5E-6 1,1E-4
Regulation of actin cytoskel. 122 1,3 3,5E-6 9,7E-5
ErbB signaling pathway 57 0,6 6,0E-6 1,5E-4
Pancreatic cancer 49 0,5 6,6E-6 1,4E-4
Purine metabolism 92 1,0 7,1E-6 1,4E-4
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Figure 2. The Wnt Pathway during mDA Differentiation of epiSCs
(A) Top ten categories of KEGG pathways associated with differentially expressed genes between day 9 MD and day 14 MD of the dopa-
minergic differentiation protocol (+SHH/FGF8). The p values were calculated using hypergeometric test and corrected by Benjamini-
Hochberg adjustment.
(B) Relative expression of the most expressed Wnt genes in floor plate and basal plate during embryonic development, from E9.5 to E12.5.
(C) qPCR for the expression of Wnt5a,Wnt5b,Wnt7a, Wnt9a, Wnt1, and Lmx1b during epiSC differentiation into DA (+SHH/FGF8) or control
(SHH/FGF8) neurons. Data represent mean ± SEM from three independent experiments.
(legend continued on next page)
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(Figure 3A), and were predicted also to directly targetWnt1
(Figure 3B).
Pitx3-GFP is a mouse line in which the mDA neurons are
exclusively labeled by the knockin GFP reporter (Zhao
et al., 2004). Interestingly both miR-34b/c and miR-
148a-3p were enriched in fluorescence-activated cell sort-
ing (FACS)-purified GFP+ cells obtained from E12.5 and
E13.5 Pitx3-GFP embryos (Figure 3C), confirming their
expression inmDA neurons in vivo. Hence, we investigated
whether miR-34b/c and miR-148a-3p could act as post-
transcriptional regulators of Wnt1. To this purpose we
performed luciferase assays by transfecting plasmids ex-
pressing both miRNAs with a pmiR-reporter containing
Wnt1 30UTR in HeLa cells. Both miR-34b/c and miR-
148a-3p were able to significantly reduce luciferase activity
(34.6% and 20%, respectively). The effect was abolished
after mutation of the predicted binding site for miR-34b/c
but not for miR-148a-3p, suggesting that only miR-34b/c
effectively binds to its predicted site atWnt1 30UTR (Figures
3B and 3D).
To further confirm thatmiR-34b/c and theWnt signaling
pathway could be involved in early phases ofmDAdifferen-
tiation, we used a dual-fluorescent GFP-reporter/mono-
meric red fluorescent protein (mRFP)-sensor plasmid
(De Pietri Tonelli et al., 2006), which allows the detection
of miRNAs at single-cell resolution. We cloned a tandem
cassette complementary to miR-34b/c in the 30 UTR of the
mRFP sensor (pDSV3-34) or mutated in the region corre-
sponding to the ‘‘seed sequence’’ of miR-34b/c (pDSV3-
34mut). This approach has been described as very efficient
for monitoring the endogenous expression of miRNAs
both in vitroand in vivo. IndifferentiatingmESCs transfected
with pDSV3-34, the expression of the mRFP sensor was
strongly reduced 72hr after transfection (left column in Fig-
ure 3E). This effect was abolished with pDSV3-34mut
(Figure 3E), thus suggesting that miR-34b/c is expressed
in vitroduring theDAdifferentiationofmESCs. Transfection
of mESCs with the empty plasmids (pDSV2 and pDSV3)
does not affect GFP or mRFP-sensor expression (Figure S1).
The endogenous miR-34b/c was also able to downregu-
late the expression of the mRFP sensor containing the
entire Wnt1 30UTR sequence downstream of the coding
sequence (CDS) (pDSV2-UTR). A reduction for the mRFP
sensor was clearly visible in mESCs transfected with
pDSV2-UTR 72 hr after transfection (second right column
in Figure 3E). Mutation in the binding site for miR-34b/c(D) Hierarchical clustering of mRNA in day 9 MD and day 14 MD of dop
The cluster was built according to the expression profiles of differen
indicates that the expression levels increased from red to green. Boxes
genes of Wnt pathway are reported on the right of the heatmap.
(E) The cartoon shows the most important genes involved in the Wnt(pDSV2-UTRmut) did not affect the mRFP-sensor expres-
sion (right column in Figure 3E).
Mir-34b/c Enhances mESC Dopaminergic
Differentiation
Ourdata suggest thatmiR-34b/chas a role inDAneurondif-
ferentiation. To further corroborate this finding, we cloned
900-bp genomic DNA encompassing the miR-34b/c clus-
ter into an inducible lentiviral vector upstream of an Ires-
GFP sequence (lenti-miR34b/c-Ires-GFP) andoverexpressed
the miR-34b/c cluster during the in vitro DA differentiation
of mESCs. mESCs were infected with the lenti-miR34b/c-
Ires-GFP vector (or with an inducible lenti-GFP as control),
treated with doxycycline for 1 day and FACS purified for
GFP. GFP+ mESCs were amplified in the absence of doxycy-
cline and then differentiated toward the DA phenotype in
the presence or absence of doxycycline for 14 days (see
scheme in Figure 4A). At the end of the differentiation,
the expression ofmiR-34cwas enriched 16-fold (Figure 4B),
while no difference was observed for miR-34c in mock-in-
fected GFP+ mESCs (Figure 4B).
The overexpression of miR-34b/c cluster induced a
downregulation in the mRNA levels for both Wnt1 and
Lmx1b (Figure 4C). Consistent with the RNA data, immu-
nostaining revealed a significant reduction of LMX1B+ cells
(Figure S2). In parallel, we observed a reduced amount of
mRNAs for Lef1 and Axin2, thus supporting a role of miR-
34b/c as a negative regulator of the Wnt signaling (Fig-
ure 4C). The overexpression of miR-34b/c also promoted
DA differentiation. Indeed, we found a significant upregu-
lation of mDA markers such as Th, Dat, Vmat2, and Pitx3
(Figure 4D). In addition, miR34b/c overexpression resulted
in a 60% increase in the number of TH+ cells compared
with control cultures (Figures 4E and 4F).
Mir-34b/c Enhances Fibroblast Transdifferentiation
into Induced Dopaminergic Neurons
It has been shown that direct reprogramming represents a
powerful source of iDA, useful for functional studies and
cell replacement approaches. Hence,we further investigated
whethermiR-34b/ccould increase theyieldofDAneurons in
suchanexperimental paradigm.To thispurpose,we infected
MEFs derived frommice expressingGFPunder the control of
the Th promoter (Sawamoto et al., 2001) with inducible
lentiviruses expressing miR-34b/c cluster in combination
with the reprogramming transcription factors Ascl1 and
Nurr1 (renamed also A and N) (Caiazzo et al., 2011).aminergic differentiation (+SHH/FGF8) and control (SHH/FGF8).
tially expressed genes of Wnt signaling pathway. The key color bar
highlight the most significant differences. The most representative
pathway. Gray arrows indicate genes trend from array data.
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Figure 3. miR-34b/c Targets Wnt1 and Is Expressed in DA Neurons
(A) Upregulated miRNAs obtained by comparing dopaminergic (+SHH/FGF8) with control protocols (SHH/FGF8) both at day 9 MD and day
14 MD. For each miRNA, the number of predicted targets identified among the downregulated Wnt signaling genes is reported according to
TargetScan algorithm. miRNAs selected for further investigation and miR-135a2 are highlighted.
(B) Schematic of the Wnt1 30UTR reporting conserved miRNAs binding sites. The wild-type (3UTR WT) and mutated (3UTR M) seed se-
quences for miR-34b/c and miR-148a-3p are highlighted.
(C) TaqMan assay for the expression of miR-34c and miR-148a-3p in FACS-purified PITX3-GFP+ and PITX3-GFP cells at E12.5, E13.5, and
E16.5. Data are normalized to the average of the reference sno-202 and represent mean ± SEM of three independent experiments.
(D) Luciferase assay. pmiR-Reports containing the wild-type (Wnt1 30UTR) or mutated (Wnt1 30UTRmut) 30 untranslated sequence for Wnt1
were co-transfected with Tet-O-FUW-miR-34b/c plus rtTA (miR-34b/c) and Tet-O-FUW-miR-148a-3p plus rtTA (miR-148a). The empty
pmiR-Report vector was used as additional control. All luciferase data have been normalized to the Renilla (RL-SV40) activity. Data
represent mean ± SEM from three independent experiments. *p < 0.01 (Student’s t test).
(E) Dual-fluorescent reporter assay based on GFP reporter and monomeric red fluorescent protein sensor (mRFP). Left columns: ESCs
transfected with; a plasmid containing a complementary sequence to miR-34b/c downstream the CDS for the mRFP sensor (pDSV3-34) or,
with a plasmid containing a sequence mutated in the region corresponding to the ‘‘seed’’ for miR-34b/c (pDSV3-34mut). Right columns:
ESCs transfected with a plasmid containing the wild-type Wnt1 30UTR (pDSV2-UTR) or mutated in the binding site for miR-34b/c (pDSV3-
UTRmut) downstream of the CDS for the mRFP sensor. Images were acquired 72 hr after transfection. Scale bars, 50 mm.
Please cite this article in press as: De Gregorio et al., miR-34b/c Regulates Wnt1 and Enhances Mesencephalic Dopaminergic Neuron Dif-
ferentiation, Stem Cell Reports (2018), https://doi.org/10.1016/j.stemcr.2018.02.006The expression of miR-34b/c in combination with Ascl1
and Nurr1 was induced 1 day after the infection by adding
doxycycline to theculturemedium.Cellswere thendifferen-
tiated for 14 days (day 14MD) before analyzing the amount
of TH+ and GFP+ cells. FACS analysis revealed that the com-
bination of miR-34b/c with ASCL1 and NURR1 (AN versus
AN + 34b/c) increased the number of GFP+ cells from
10.1% ± 1.7% to 19.5% ± 2.4% (Figures 5A and 5B) while
miR-34b/c alone or in combination with ASCL1 was unable6 Stem Cell Reports j Vol. 10 j 1–14 j April 10, 2018to induceGFP expression (our unpublished data). Such a dif-
ferencewas furtherverifiedbyanincreased levelofThmRNA
(Figure 5H) and the number of TH+ cells following quantifi-
cation of captured images (Figures 5C and 5E).
The addition of miR-34b/c affects terminal differentia-
tion of DA neurons. Indeed, the expression of late mDA-
specific markers such as Dat and Vmat2 were increased at
mRNA level when miR-34b/c was combined with ASCL1
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Figure 4. Enforced Expression of miR-34b/c Promotes ESC DA Differentiation by Downregulating Wnt Signaling
(A) Schematic representation of the experimental procedure. mESCs were infected with an inducible lentiviral vector expressing miR-34b/c
upstream of an Ires-GFP sequence. Cells were FACS purified, amplified, and differentiated toward the DA phenotype.
(B) TaqMan assay for miR-34c in FACS purified mESCs in presence or absence of doxycycline (DOX). Data were normalized to the average of
the reference sno-202. Data represent mean ± SEM. *p < 0.01 (Student’s t test).
(C and D) qPCR analysis of genes related to the Wnt pathway (Wnt1, Lmx1b, Axin2, and Lef1; C) and dopaminergic lineage (Th, Vmat2, Dat,
and Pitx3; D) at day 14 MD in the presence or absence of DOX. Data represent mean ± SEM from three independent experiments. *p < 0.01
(Student’s t test).
(E and F) Immunostaining and quantifications for TH in mESCs at day 14 MD (E). Counting was performed from 20 randomly selected fields
for each condition, in three independent experiments. Data represent mean ± SEM. *p < 0.05 relative to DOX (Student’s t test). A higher-
magnification imageofDA-differentiatedESCs is shownin(F). TH(red)andTUBB3(green). Scalebars represent200mmin(E)and100mmin(F).
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ferentiation, Stem Cell Reports (2018), https://doi.org/10.1016/j.stemcr.2018.02.006To understand whether miR-34b/c acts by affecting cell
cycle progression, we infected the neuronal cell line A1
(Colucci-D’Amato et al., 1999) with an inducible lenti-
miR34b/c-Ires-GFP (lenti-miR34b/c-Ires-GFP) or a control
lenti-GFP virus and analyzed FACS-purified GFP+ cells
by quantitating of DNA content. Forty-eight hours after
infection, we observed that cultures infected with miR-
34b/c (lenti-miR34b/c) contained more cells in G0/G1
(74.5% ± 3%) than those in control culture (61% ± 1%, Fig-
ures S3A and S3B).
To investigate whether the modulation of Wnt
signaling may have a role in the transdifferentiationprocess, we infected MEFs derived from TH-GFP mice
with Ascl1, Nurr1, and miR-34b/c in the presence of
CHIR99021 (chiron), a selective inhibitor of GSK3b that
can mimic Wnt activation. We found that while chiron
did not alter the level of Wnt1 (AN34C in Figure 5F),
it elicited a strong upregulation of Lef1 (AN34C in Fig-
ure 5G), suggesting an activation of Wnt signaling as
expected. This effect was accompanied by a significant
reduction in both the number of TH+ neurons (AN34C
in Figures 5C, 5D, and 5H) and the transcript level of
several mDA markers such as Vmat2 and Dat (AN34C in






























































































































Figure 5. miR-34b/c Enhances Dopaminergic Transdifferentiation
(A and B) MEFs, derived from TH-GFP mice, transdifferentiated into DA neurons (iDA) with; ASCL1 and NURR1 (AN) or; ASCL1, NURR1 and
miR-34b/c (AN34) and analysed by FACS (A). The percentage of TH-GFP+ cells is shown in (B).
(C–E) Representative pictures of iDA obtained with AN, AN34, or AN34 plus CHIR99021 (AN34C), a potent activator of the Wnt pathway (C),
and relative quantification (D). Scale bar represents 100 mm. (E) A representative image of iDA neurons obtained with AN34; TH is in green
and TUBB3 in red. Scale bar represents 25 mm.
(F and G) qPCR forWnt1 (F) and its downstream target Lef1 (G) of MEFs transdifferentiated with ASCL1 alone (A), ASCL1 and NURR1 (AN), or
ASCL1, NURR1, and miR-34b/c in the presence or absence of chiron (AN34 or AN34C).
(H–J) qPCR for the expression of dopaminergic genes Th (H), Dat (I), and Vmat2 (J) in iDA obtained with AN, AN34, or AN34C. qPCR data for
gene expression have been normalized to the average of the reference gene Hmbs.
Data represent mean ± SEM from three independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001 (Newman-Keuls test).
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Active
MEF-derived iDA by miR-34b/c direct reprogramming also
contains higher amounts of dopamine, as shown after
staining with an anti-DA antibody (Figures 6A and 6B).
Higher amounts of double-positive (DA+, TH-GFP+) cells
(16.1% ± 2.3% versus 6.9% ± 2.5%) were identified when
miR-34b/c was included in the reprogramming cocktail
(AN34 versus AN) (Figure 6B). Similarly, a higher content of
dopaminewas also shownbyhigh-performance liquid chro-
matography (HPLC) measurements (Figure 6C), suggesting
an increased dopamine synthesis inmiR34-b/c-derived iDA.8 Stem Cell Reports j Vol. 10 j 1–14 j April 10, 2018To directly demonstrate that miR-34b/c-derived iDA are
functional, we measured the action potential by perform-
ing targeted whole-cell electrophysiological recordings.
TH-GFP+ cells derived from miR-34b/c displayed active
neuronal properties. In extracellular recordings, we re-
corded spontaneous action potential firing at 3.93 ±
2.28 Hz in four cells. These events were reversibly blocked
by TTX (1 mM), suggesting that they were mainly mediated
by sodium currents (Figure 6D). In whole-cell recordings,
depolarizing current injection of increasing amplitudes
from a holding potential of 55/60 mV (1 s, Figure 6E)
evoked trains of action potentials in five cells, which were
Figure 6. miR-34b/c-Derived iDA Cells Are Functionally Active
(A and B) MEFs derived from TH-GFP mice were transdifferentiated in the presence of AN or AN34 and immunostained with and anti-DA
antibody. Arrowheads indicate double-positive (DA+; TH-GFP+) cells. Scale bar represents 50 mm. Quantification of DA+; TH-GFP+ cells is
shown in (B). Data represent mean ± SEM from three independent experiments. *p < 0.05; **p < 0.01 (Newman-Keuls test).
(C) HPLC analysis of dopamine content in AN- and AN34-derived iDA cells; Data represent mean ± SEM from three independent experi-
ments; **p < 0.01 (Student’s t test).
(D–H) Spontaneous firing activity of iDA neurons during extracellular single-unit recording is reversibly inhibited by TTX (D). In whole-cell
recordings, injection of depolarizing current steps from a holding potential of54 mV evoked trains of action potentials (E, left) that were
blocked by TTX (E, right), suggesting that they are mediated by fast Na+ currents. Hyperpolarization-activated membrane currents (F) and
sag potentials (G) indicate the expression of Ih in iDA neurons. Typical voltage-dependent inward and outward currents (H) are also
present in iDA neurons.
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those seen in ex vivo DA neurons. In response to the same
protocol, another group of cells displayedmembrane depo-
larization that did not reach the threshold for action poten-
tial generation (not shown).
In voltage-clamp recordings (Figure 6F, Vh =  60 mV),
we applied hyperpolarizing voltage steps (to 120 mV,
20-mV increments) to activate the hyperpolarization-acti-
vated inward current, Ih, largely expressed in vivo by DA
neurons of the substantia nigra pars compacta (Grace and
Onn, 1989; Mercuri et al., 1995) and to a lesser extent
by some neurons of the ventral tegmental area (Krashia
et al., 2017) Two out of the 25 recorded GFP+ cells
displayed a small Ih (Figure 6F) and a sag potential inresponse to hyperpolarizing current injections in current
clamp mode (Figure 6G). Voltage-gated Na+ and K+ cur-
rents elicited by depolarizing voltage steps are also shown
(Figure 6H). Taken together, these data confirm that
miR-34b/c-derived iDA behave as functional active DA
neurons.DISCUSSION
Mir-34b/c Is Expressed inmDANeurons and Regulates
Wnt1
In themidbrainWnt signaling is required for DAneurogen-
esis, and among the multiple canonical Wnts Wnt1 andStem Cell Reports j Vol. 10 j 1–14 j April 10, 2018 9
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ferentiation (Arenas, 2014). Here we investigate whether
miRNAs could have a role in DA neuron differentiation
alongside the Wnt signaling genes, since it was shown
recently that restriction of Wnt1 and the downstream
Wnt signaling occurs during mDA development and is
achieved by a feedback loop including miR-135a2-5p that
acts by repressing Lmx1b, and modulating WNT1/Wnt
signaling (Anderegg et al., 2013). Interestingly we identi-
fied miR-135a2-5p as the miRNA with the highest
number of predicted targets among the genes associated
with Wnt pathway, which were downregulated at the late
phases of our DA differentiation experiment (between
day 9 and day 14 MD), confirming the relevance of our
analysis aimed at identifying novel candidate miRNAs
playing a role during DA differentiation. This approach al-
lowed us to identify also miR-148a-3p and miR-34b/c, two
miRNAs, enriched in FACS-purified mDA neurons, which
are predicted to target Wnt1 30UTR. Nevertheless only
miR-34b/c binds the Wnt1 30UTR and represses luciferase
activity.
While the function of miR-34a in regulating Wnt
signaling has been shown in both cancer progression
and development (Kim et al., 2011, 2013), the involve-
ment of miR-34b/c in this pathway has been largely ne-
glected mainly because of the assumption that miRNAs
sharing identical seed sequences target the same genes.
It is now clear, however, that the role of individual miRNA
should be considered relative to the cellular context and
that sequence determinants outside the seed might pro-
foundly affect miRNA binding through undefined mecha-
nisms (Navarro and Lieberman, 2015; Ebner and Selbach,
2014).
Interestingly miR-34b/c was previously shown to be
downregulated in postmortem brain of PD patients at
different stages of pathology (Miñones-Moyano et al.,
2011). Nevertheless, few papers described the involvement
of miR-34b/c in mDA neurons or reported DA-related phe-
notypes in miR-34b/c knockout mice (Comazzetto et al.,
2014; Concepcion et al., 2012). This may be explained by
the redundancy between the miR-34 family that includes
three members of miR-449 (a, b, and c) in addition to
miR-34a, b, and c. It is plausible that in vivo fine-tuning
of the Wnt signaling might require the action of several
miRNAs targeting simultaneously different actors of the
pathway. In this context, it is not surprising that deletion
of a single gene cluster has limited or no effects on mDA
development.
Thus, although we identify Wnt1 as a target of miR-
34b/c, it is unlikely that downregulation of Wnt1 by itself
could drive mDA differentiation. We believe, indeed, that
the miR-34b/c-mediated downregulation of Wnt1 is part
of a complex series of events requiring the simultaneous10 Stem Cell Reports j Vol. 10 j 1–14 j April 10, 2018intervention of other genes and pathways whose final
aim is to define DA identity.
Mir-34b/c Potentiates iDA Reprogramming
Direct reprogramming has been used to achieve dif-
ferentiation of fibroblasts into specific subtypes of mature
neurons (Vierbuchen et al., 2010) and is considered a
promising approach in terms of both regenerative medi-
cine and modeling human diseases. For DA neurons this
result has been achieved by combinatorial expression of
early and late mDA transcription factors such as Ascl1,
Lmx1a, and Nurr1 (Caiazzo et al., 2011). miRNAs are
considered a very promising additional tool to increase
the yield of specific neuronal populations, as was
shown by miR-9 and miR-124 (Victor et al., 2014). A
similar mechanism may be proposed also for miR-34b/c,
which increases mDA differentiation efficiency by
facilitating cell cycle exit through the upregulation of
a potent cyclin-dependent kinase inhibitor p21 (our
unpublished data). The expression of miR-34b/c during
the differentiation phases in combination with ASCL1
and NURR1 represses proliferation, promotes terminal
differentiation, and downregulates Wnt1, which was
maintained at high level by constant expression of
Ascl1 (Rheinbay et al., 2013). The importance of miR-
34b/c has also emerged in previous reports that placed
miR-34 downstream of p53 (Kim et al., 2011). miRNAs
might thus be required to shut down molecular programs
to counteract differentiation. In DA neurons this is
the case for miR-124 (Jiang et al., 2015) and miR-34b/c,
which facilitate the generation of functional active DA
neurons.
In the brain, miRNAs confer robustness to specific
developmental processes and contribute to the matura-
tion of specific neuronal circuits (Amin et al., 2015;
Choi et al., 2008; Conaco et al., 2006; Cuellar et al.,
2008; Tan et al., 2013, Stark et al., 2005). It is thus
possible that miR-34b/c acts, at least in part, along the
same axis by restraining Wnt signaling in the midbrain,
thus facilitating cell cycle exit and allowing progenitor
differentiation toward mature DA neurons. Taken
together, our findings suggest that the achievement of
functional mDA neurons requires the control over time
of different stimuli (such as those mediated by the
Wnt signaling) that are essential during early progenitor
differentiation. It is plausible that other miRNAs are
involved in the DA-differentiation process through the
regulation of different pathways. It will be thus compel-
ling to attain their identification in order to further under-
stand the process of DA differentiation and increase the
overall yield of DA neurons, as well as to improve their
features in terms of both molecular and physiological
properties.
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Ethics Statement
All procedures involvingmice were carried out in strict accordance
with national and European law.
EpiSC DA Differentiation
Dopaminergic differentiation of epiSC was performed as previ-
ously described (Jaeger et al., 2011). The sequential steps of the pro-
tocol are described in the Supplemental Experimental Procedures.
RNA Extraction and qPCR
RNA was extracted from cells and tissues using the TRI-Reagent
(Sigma, Milan, Italy) or miRVana miRNA isolation kit (Ambion,
Milan, Italy). qPCR was carried out at least in triplicate samples
using Power SYBR Green or TaqMan microRNA assays (Applied
Biosystems, Milan, Italy) and analyzed as described in Supple-
mental Experimental Procedures.
Microarray Data Analysis
Microarray data were performed on epiSC differentiated toward
theDA phenotype as described in Supplemental Experimental Pro-
cedures. Data are available at GEO: GSE110270.
Gene ontology and pathway analysis were performed on
microarray data using the DAVID functional annotation tool
(https://david.ncifcrf.gov) (Huang et al., 2007b) to find over-
represented biological themes. Default DAVID parameters were
used. To identify the pathways altered, we used the online tool
available from Kanehisa laboratories, KEGG Mapper (Kanehisa
et al., 2010). Regarding putative miRNA-mRNA interaction, for
the identification of miRNA responsive elements within the
30 UTRs of protein coding genes, we used TargetScan algorithm
(Lewis et al., 2005).
PITX3-GFP+ Cell Analysis
Freshly dissected ventral midbrains of Pitx3-GFP embryos were
dissociated using a Papain dissociation system (Worthington, Mi-
lan, Italy). GFP-positive and -negative cells were isolated by a Cyto-
peia Influx Cell sorter or BD FACSAria III using previously
described settings (Jacobs et al., 2011) and collected in RNAlater
(Thermo Fisher Scientific, Milan, Italy). RNA was then purified
by an miRVana miRNA isolation kit and analyzed by TaqMan
MicroRNA Assays as described in Supplemental Experimental
Procedures.
Immunocytochemistry
The following primary antibodies were used with the protocol
described in Supplemental Experimental Procedures: anti-TUJ1
mouse 1:1,000 (Covance, Rome, Italy, catalog #MMS-435P),
anti-TH rabbit 1:500 (Chemicon, Milan, Italy, cat. #AB152),
anti-LMX1B rabbit (a gift from Dr. Antonio Simeone), and
anti-GFP mouse (Thermo Fisher Scientific, cat. #A11120).
Dopamine staining was performed with an anti-dopamine rabbit
(IS1005) + STAINperfect immunostaining kit A (SP-A-1000)
(ImmuSmol SAS, Bordeaux, France) according to the manufac-
turer’s instruction.Image Quantification
Images were acquired using a Leica TCS SP5 confocal microscope.
Quantification was performed either by using the cell counter
plugin in the ImageJ software on randomly selected fields or by
performing pixel analysis quantifications with a custom-made
ImageJ plugin (rsb.info.nih.gov/ij/download/). In both cases
quantification was performed from at least three independent
experiments.
Luciferase Assay
The assay was performed by using the Luciferase Reporter Assay
System (Promega, Milan, Italy), following the manufacturer’s
instructions. The 30 UTR-containing pmiR-Report was co-trans-
fected with the Tet-O-FUW miRNA-overexpressing vector
and the rtTA-expressing vector in HeLa cells. A pRL-SV40
Renilla luciferase reporter vector (Promega) was also used to
quantify the transfection efficiency. Firefly luciferase lumines-
cent signal was normalized on the Renilla luciferase signal. For
each assay, a control experiment with the empty pmiR-
Report vector or without overexpressing any miRNA were
performed.
Dual-Fluorescent Reporter Sensor
DFRS plasmids were kindly provided by Prof. Wieland B. Huttner.
Cloning strategy was performed as previously described (De Pietri
Tonelli et al., 2014) using the oligos listed in Supplemental Exper-
imental Procedures. Plasmids were transfected into control (basal)
and differentiating mESCs by Lipofectamine. Fluorescence was
monitored every day until 72 hr post transfection.
Lentivirus Preparation and Viral Infection
cDNAs for mAscl1, mNurr1, and 983 base pairs encompassing the
pri-miRNA-34b/c cluster were cloned into Tet-O-FUW or Tet-O-
FUW-Ires-GFP lentiviral vectors under the control of the tetracy-
cline operator. Lentiviruses were packaged in HEK293T cells
as previously described (Caiazzo et al., 2011) (see Supplemental
Experimental Procedures for details). Gene expression was tested
by qPCR, while miRNA levels were measured by TaqMan assay.
Infections were performed in combination of rtTA transactivator
viruses supplied with doxycycline (2 mg/mL, Clontech).
Fluorescence-Activated Cell Sorting
TH-GFP+ iDA cells or mES-miR-34b/c-GFP+ cells were trypsinized,
washed, and sorted or analyzed with a BD FACSAria II. Cells were
collected in TRI-Reagent (Sigma) for RNA extraction or in cell cul-
ture medium for subsequent amplification.
Induced Dopaminergic Neuron Generation
iDA neurons were generated from MEFs as previously described
(Caiazzo et al., 2011). In brief, MEFs were infected with rtTA,
Tet-O-FUW-mAscl1, Tet-O-FUW-mNurr1, and Tet-O-FUW-miR-
34b/c lentiviruses in MEF medium with addition of doxycycline
(2 mg/mL, Sigma). After 48 hr the medium was replaced with
neuronal inducing medium (DMEM/F12, B27, and penicillin/
streptomycin [all fromThermo Fisher Scientific]) containing doxy-
cycline and cells cultured for 14 days.Stem Cell Reports j Vol. 10 j 1–14 j April 10, 2018 11
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Whole-cell patch-clamp and conventional single-unit extracel-
lular recordingswere performed according to published procedures
(Guatteo et al., 2013, 2017) from visually identified TH-GFP+ cells
plated on glass coverslips at 12–16 days post infection. See Supple-
mental Experimental Procedures for details.
Statistical Analysis
All statistical analyses were performed using GraphPad Prism
(GraphPad Software). Significance of differences was assessed by
one-way ANOVA followed by Newman-Keuls post hoc test for
intergroup comparisons or by Student’s t test when cultures were
compared with the corresponding control or with vehicle.
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GEO: GSE110270.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
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